# Zoetis Inc.  Share Price Target ‘$205.01’, now 31.0% Upside Potential

- Link: https://www.directorstalkinterviews.com/zoetis-inc-share-price-target-205-01-now-31-0-upside-potential/4121187099
- Published: 2025-02-20T16:07:08+00:00
- Author: Charlotte Edwards

**Zoetis Inc.** which can be found using ticker (ZTS) now have 17 market analysts
covering the stock. The analyst consensus now points to a rating of ‘buy’. The range
between the high target price and low target price is between $244.00 and $171.00
and has a mean share price target at $205.01. (at the time of writing). Given that
the stocks previous close was at $156.48 this would imply there is now a potential
upside of 31.0%. The 50 day MA is $168.63 while the 200 day moving average is $177.31.
The market cap for the company is 70.14B. Currently the stock stands at: $156.64
USD

 The potential market cap would be $91,896,235,777 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 28.64, revenue per share of $20.38
and a 14.87% return on assets.

Zoetis Inc. is an animal health company. The Company is focused on the discovery,
development, manufacture and commercialization of medicines, vaccines, diagnostic
products and services, biodevices, genetic tests and precision animal health technology.
It commercializes products across eight core species: dogs, cats and horses and 
cattle, swine, poultry, fish and sheep and within product categories, such as vaccines,
anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated
feed additives and animal health diagnostics. The Company operates through two segments:
the United States and International. Within each of these operating segments, it
offers a product portfolio for both companion animal and livestock customers. The
Company market its products in approximately 45 countries across North America, 
Europe, Africa, Asia, Australia and South America. The Company’s products are sold
in more than 100 countries.

Share on:
